Total Funding
67
23
Total FundingGrant raised
Growth Score 67 in past quarter
-4 pts
Heat Score 23 in past quarter
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
171473
TumorGen is a biotechnology company.
- Jeffrey Allen: CEO
About the Company
TumorGen is developing the tools necessary to help create new drugs that specifically target metastases. Its technology is a versatile microfluidic platform that is pioneering drug discovery against circulating tumor cell clusters, the drivers of metastasis.